 <h1>Nalex-DH Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>hydrocodone / phenylephrine</i></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about hydrocodone / phenylephrine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Nalex-DH.</p><p><i>Applies to hydrocodone/phenylephrine: oral liquid, oral syrup</i></p><h3>General</h3><p>The most common adverse events were occasional drowsiness, dry mouth, blurred vision, dizziness, mild mental stimulation, and gastric irritation.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Rare</b> (less than 0.1%): Occasional drowsiness, dizziness, mild mental stimulation</p><p><b>Postmarketing reports</b>: Convulsions<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Postmarketing reports</b>: Breathing difficulties<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Postmarketing reports</b>: Urinary retention, androgen deficiency<sup>[Ref]</sup></p><p>Androgen deficiency:</p><p>-Chronic opioid use may affect the hypothalamic-pituitary-gonadal axis leading to androgen deficiency.</p><p>-Symptoms may include low libido, impotence, erectile dysfunction, amenorrhea, and infertility.</p><p>-Opioids role in androgen deficiency have not been evaluated where other factors (medical, physical, lifestyle, psychological) have been adequately controlled.</p><p>-Perform laboratory evaluation for symptoms of androgen deficiency.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Rare</b> (less than 0.1%): Mild mental stimulation</p><p><b>Postmarketing reports</b>: Hallucinations<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Postmarketing reports</b>: Rapid heart rate, reflex bradycardia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Blurred vision<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Allergic reaction<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Rare</b> (less than 0.1%): Dry mouth, gastric irritation<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,   Inc. "Canadian Product Information." O 0 (2015):</p><p id="ref_2">2. "PDR Generics. 4th ed." Montvale, NJ: Medical Economics  (1998):</p><h2>More about Nalex-DH (hydrocodone / phenylephrine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: upper respiratory combinations</li>
<li>FDA Alerts (1)</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Nalex-A</li>
<li>Nalex A 12</li>
<li>Nalex AC</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Cough and Nasal Congestion</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>